Trial intelligence / Profile preview

IA-SUCCESS: Intra-Arterial Alteplase After Successful Recanalization in Stroke

NCT06768138Phase 3Recruiting

Sponsor
CHRU de Nancy - Hôpital Central
Start
Jun 2025
Primary completion
Sep 2028
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 3 trial of tissue-plasminogen activator in ischemic stroke, sponsored by CHRU de Nancy - Hôpital Central. Started Jun 2025; status: recruiting.

02

Drugs

tissue-plasminogen activator
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT06768138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06768138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call